Release Date: 31/10/11 08:18 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 851.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%